Skip to content

Characterization of H1N1 and interferon-β-responsive long non-coding RNAs using single-cell CRISPRi in human lung epithelial and immune cell lines 2260688

Jul 2026 · Journal of Immunology · 0 citations

TL;DR

Two novel interferon-responsive human lncRNAs that may play important roles in the regulation of the host interferon response across different cell types are identified.

Abstract

Despite 36,000 long non-coding RNAs (lncRNAs) annotated in the human genome, functional characterization remains limited, and the roles of lncRNAs in the interferon (IFN) response are largely unknown. We previously identified VILMIR as an IFN-stimulated lncRNA that enhances the host IFN response. Through analysis of public bulk RNA-seq datasets, we identified two additional lncRNAs that are consistently upregulated following H1N1 influenza infection and interferon-β (IFN-β) treatment. This study aims to identify immune genes that are perturbed by candidate lncRNA knockdowns (KDs) and explore the relationship between KD efficiency of lncRNA-targeting guide RNAs and the scale of transcriptomic perturbations. To investigate the roles of these lncRNAs, we used CRISPRi to generate stable KD cell lines in human lung epithelial cells, monocytes, and T-lymphoblasts. These cell lines were treated with IFN-β for 6 hours, and mock versus IFN-treated samples were analyzed using 10x CRISPRi scRNA-seq analysis. Transcriptome analysis of each lncRNA KD line compared to controls revealed a set of differentially expressed immune genes in response to IFN-β stimulation. In summary, we have identified two novel interferon-responsive human lncRNAs that may play important roles in the regulation of the host interferon response across different cell types. The results provide mechanistic targets for future studies and serve as preliminary data for future large-scale screens of candidate lncRNAs. National Institutes of Health Grant R21AI147187 Immune Response Regulation: Molecular Mechanisms (IRM)

View source

Similar papers

Open access Jul 2026

Ebola virus exploits host lncRNA LINC01740 to enhance ATF3 and suppress antiviral immune responses 2259953

A novel LINC01740—ATF3—IFN-I regulatory axis driving immune evasion and viral persistence is shown, highlighting lncRNAs as potential antiviral therapeutic targets and LINC01740 as a novel host lncRNA co-opted by EBOV to enhance ATF3 and suppress antiviral responses.

Narasimha Tanuj Gunturu, Anumarla Gopal, Marija Djurkovic-Lopez et al. · 0 citations
Open access Jul 2026

Ebola virus exploits host lncRNA LINC01740 to enhance ATF3 and suppress antiviral immune responses

Ebola virus (EBOV) infection causes severe hemorrhagic fever marked by dysregulated cytokine production, impaired antiviral defenses, and multi-organ failure. Macrophages are primary targets of EBOV, and viral replication profoundly alters macrophage transcriptional programs, driving hyperinflammation. Although long no...

O. Shtanko, Tanuj Gunturu, Anumarla Gopal et al. · 0 citations
Open access Jan 2026

Integrative Pan‐Cancer Characterization of lncRNA UPK1A‐AS1 and Its Role in Hypoxia‐Associated Sorafenib Resistance in Hepatocellular Carcinoma

It is suggested that UPK1A-AS1 is a hypoxia‐inducible oncogenic lncRNA that plays dual roles in cancer, with cancer type‐dependent associations with progression and immune modulation across malignancies and mechanistically mediating hypoxia‐associated drug resistance in HCC.

Ze-Kai Li, Min Luo, Shu-Sen Fang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.